Brendan Boyle (D-PA)

Women and Lung Cancer Research and Preventive Services Act of 2025

H.R. 2319 · House bill Health

A Democratic bill with 2 Republican cosponsors · See all 2 cosponsors

Last activity — Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 380.

Waiting for a floor vote in the other chamber

Passed one chamber and is on the other chamber's calendar.

The calendar is a queue, not a date. The majority leadership decides what comes to the floor and when; much of what is placed on it is never called, and a bill that is never called simply expires with the Congress.

Its path through Congress

  1. Introduced
  2. Passed House voice vote
  3. Awaiting Senate
  4. On Senate calendar

The House by voice vote (members called out yes or no together): no member's position on it was recorded.

What this bill would do

This Act directs the Secretary of Health and Human Services to lead an interagency review focused on lung cancer research. The review will specifically look at research involving women and underserved populations that meet certain screening criteria. It also aims to identify ways to increase access to preventive services and create public awareness campaigns. The Secretary must consult with the Secretaries of Defense and Veterans Affairs during this process. Additionally, the review will look for innovative research opportunities and improvements in imaging technology. Finally, a report on these findings must be submitted to Congress within two years of the Act's enactment.

Yes· 3 of 11

  • Scored +5

    Would women be better off under this?

    The bill specifically prioritizes research and preventive service access for women regarding lung cancer.

  • Scored +5

    Does this make health care easier to get in general?

    The bill directs a review to expand access to lung cancer preventive services and a national screening strategy.

  • Scored +4

    Does this put more money into medical research?

    The act mandates a comprehensive review to identify opportunities for the acceleration of lung cancer research.

The opposite

No question was scored the opposite.